Akèy › Kansè nan tete › Connecticut › Stamford
Etid klinik pou Kansè nan tete nan Stamford, CT
9 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Stamford (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Ap rekriteFaz 3
- Stamford Hospital ( Site 0049), Stamford
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Ap rekriteFaz 3
- Smilow Cancer Hospital Care Center - Greenwich, Greenwich · 5 mi lwen
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Ap rekriteFaz 3
- Paradigm New York Cancer and Blood Specialists, Bay Shore · 27 mi lwen
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Stamford Hospital/Bennett Cancer Center, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mi lwen
- ak 3 plis
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Ap rekriteFaz 2
- Stamford Hospital, Stamford
- Smilow Cancer Hospital Care center at Greenwich, Greenwich · 5 mi lwen
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- Stamford Hospital/Bennett Cancer Center, Stamford
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Ap rekriteFaz 3
- Smilow Cancer Hospital - Long Ridge, Stamford
- Smilow Cancer Hospital - Greenwich, Greenwich · 5 mi lwen
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Ap rekriteFaz 2
- Stamford Hospital, Stamford
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mi lwen
- Northwell Health Cancer Institute at Huntington, Greenlawn · 16 mi lwen
- ak 1 plis
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Stamford
- Kansè poumon10 etid
- Kansè Poumon ki pa ti selil8 etid
- Migrèn6 etid
- Obèsite6 etid
- Kansè pwostat5 etid
- Kansè ovè5 etid
- Kansè pankreyas4 etid
- Maladi kadyovaskilè4 etid
- Sipwa4 etid
- Kansè Metastatik3 etid
- Maladi Nèwolojik3 etid
- Ensifizyans kadyak3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.